Restricted accessResearch articleFirst published online 2025-05
Fermented Strawberry ( Fragaria x Ananassa Duch.) Mitigates Renal Fibrosis in a Unilateral Ureteral Obstruction Model by Reducing Inflammation,Oxidative Stress,and Regulating Smad Signaling
Renal fibrosis is a common outcome in many progressive renal diseases. Unilateral ureteral obstruction (UUO) is known to induce oxidative stress and inflammation in the kidneys, leading to the development of renal fibrosis. Fermented strawberry (Fragaria x ananassa Duch.) possesses antioxidant properties; however, its effect on renal fibrosis remains unclear. This study aimed to evaluate the impact of fermented strawberry dry powder (FSP) on renal fibrosis by assessing proinflammatory cytokines, oxidative stress markers, and underlying mechanisms. Male Sprague-Dawley rats were subjected to UUO surgery to induce tubulointerstitial fibrosis and obstructive nephropathy. Ten days postsurgery, the rats were randomly divided into four groups (n = 6), including a sham-operated control group. FSP was administered orally at doses of 0.05 or 0.5 g kg−1 body weight daily for 21 days. FSP treatment significantly improved renal function, reduced tubular dilation, and decreased interstitial volume in UUO rats. FSP decreased levels of tumor necrosis factor-α and interleukin-6, while enhancing the activities of antioxidant enzymes such as superoxide dismutase and catalase. Treatment with 0.05 and 0.5 g kg−1 FSP resulted in a reduction of collagen deposition in the kidneys by 49% and 69%, respectively, compared with UUO group. FSP increased E-cadherin expression and decreased α-smooth muscle actin level in the kidneys of UUO rats. Furthermore, FSP reduced transforming growth factor-β and Smad2/3 levels while upregulating Smad7 expression. These findings suggest that FSP mitigates renal tubulointerstitial fibrosis, likely through modulation of Smad signaling and attenuation of oxidative stress and inflammation.
Get full access to this article
View all access options for this article.
References
1.
HuangR, FuP, MaL. Kidney fibrosis: From mechanisms to therapeutic medicines. Sig Transduct Target Ther, 2023; 8(1):129; doi: 10.1038/s41392-023-01379-7
HumphreysBD. Mechanisms of renal fibrosis. Annu Rev Physiol, 2018; 80:309–326; doi: 10.1146/annurev-physiol-022516-034227
4.
BhargavaV, SinghK, MeenaP, et al.Nephrogenic systemic fibrosis: A frivolous entity. World J Nephrol, 2021; 10(3):29–36. http://creativecommons.org/Licenses/by-nc/4.0; doi: 10.5527/wjn.v10.i3.29
5.
KuppeC, IbrahimMM, KranzJ, et al.Decoding myofibroblast origins in human kidney fibrosis. Nature, 2021; 589(7841):281–286; doi: 10.1038/s41586-020-2941-1
6.
OtsukiT, FukudaN, ChenL, et al.Twist-related protein 1 induces epithelial-mesenchymal transition and renal fibrosis through the upregulation of complement 3. PLoS One, 2022; 17(8):e0272917; doi: 10.1371/journal.pone.0272917
7.
RenLL, LiXJ, DuanTT, et al.Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities. Chem Biol Interact, 2023; 369:110289; doi: 10.1016/j.cbi.2022.110289
8.
YuXY, SunQ, ZhangYM, et al.TGF-β/Smad signaling pathway in tubulointerstitial fibrosis. Front Pharmacol, 2022; 13:860588; doi: 10.3389/fphar.2022.860588
9.
TaoS, YangL, WuC, et al.Gambogenic acid alleviates kidney fibrosis via epigenetic inhibition of EZH2 to regulate Smad7-dependent mechanism. Phytomedicine, 2022; 106:154390; doi: 10.1016/j.phymed.2022.154390
10.
AhmadSNS, Kalantary-CharvadehA, HamzaviM, et al.TGF-β1 receptor blockade attenuates unilateral ureteral obstruction-induced renal fibrosis in C57BL/6 mice through attenuating Smad and MAPK pathways. J Mol Histol, 2022; 53(4):691–698; doi: 10.1007/s10735-022-10078-6
11.
WeiX, HouY, LongM, et al.Advances in energy metabolism in renal fibrosis. Life Sci, 2023; 312:121033; doi: 10.1016/j.lfs.2022.121033
12.
GargSS, GuptaJ. Polyol pathway and redox balance in diabetes. Pharmacol Res, 2022; 182:106326; doi: 10.1016/j.phrs.2022.106326
13.
ZhouX, LiuZ, YingK, et al.WJ-39, an aldose reductase inhibitor, ameliorates renal lesions in diabetic nephropathy by activating Nrf2 signaling. Oxid Med Cell Longev, 2020; 2020:7950457; doi: 10.1155/2020/7950457
14.
LuQ, WangWW, ZhangMZ, et al.ROS induces epithelial-mesenchymal transition via the TGF-beta1/PI3K/Akt/mTOR pathway in diabetic nephropathy. Exp Ther Med, 2019; 17(1):835–846; doi: 10.3892/etm.2018.7014
15.
HotchkissAT, ChauHK, StrahanGD, et al.Structural characterization of strawberry pomace. Heliyon, 2024; 10(9):e29787; doi: 10.1016/j.heliyon.2024.e29787
16.
AboueleneinD, AcquaticciL, AlessandroniL, et al.Volatile profile of strawberry fruits and influence of different drying methods on their aroma and flavor: A review. Molecules, 2023; 28(15):5810; doi: 10.3390/molecules28155810
17.
ZeliouK, PapasotiropoulosV, ManoussopoulosY, et al.Physical and chemical quality characteristics and antioxidant properties of strawberry cultivars (Fragaria × ananassa Duch.) in Greece: Assessment of their sensory impact. J Sci Food Agric, 2018; 98(11):4065–4073; doi: 10.1002/jsfa.8923
18.
RutledgeGA, FisherDR, MillerMG, et al.The effects of blueberry and strawberry serum metabolites on age-related oxidative and inflammatory signaling in vitro. Food Funct, 2019; 10(12):7707–7713; doi: 10.1039/C9FO01913H
19.
GazwiHSS, HassanMSH, IsmailHA, et al.The hypoglycemic and hypolipidemic effects of polyphenol-rich strawberry juice on diabetic rats. Plant Foods Hum Nutr, 2023; 78(3):512–519; doi: 10.1007/s11130-023-01079-1
20.
HoltRR, ZuelchML, CharoenwoodhipongP, et al.Effects of short-term consumption of strawberry powder on select parameters of vascular health in adolescent males. Food Funct, 2020; 11(1):32–44; doi: 10.1039/C9FO01844A
21.
Álvarez-FernándezMA, CerezoAB, Cañete-RodríguezAM, et al.Composition of nonanthocyanin polyphenols in alcoholic-fermented strawberry products using LC-MS (QTRAP), high-resolution MS (UHPLC-Orbitrap-MS), LC-DAD, and antioxidant activity. J Agric Food Chem, 2015; 63(7):2041–2051; doi: 10.1021/jf506076n
22.
SpagnuoloC, MocciaF, TedescoI, et al.Stillage waste from strawberry spirit production as a source of bioactive compounds with antioxidant and antiproliferative potential. Antioxidants (Basel), 2023; 12(2):421; doi: 10.3390/antiox12020421
23.
Martinez-KlimovaE, Aparicio-TrejoOE, TapiaE, et al.Unilateral ureteral obstruction as a model to investigate fibrosis-attenuating treatments. Biomolecules, 2019; 9(4):141; doi: 10.3390/biom9040141
24.
LeeWC, JaoHY, HsuJD, et al.Apple polyphenols reduce inflammation response of the kidneys in unilateral ureteral obstruction rats. J Funct Food, 2014; 11:1–11; doi: 10.1016/j.jff.2014.08.010
25.
NishimuraM, MuroT, KoboriM, et al.Effect of daily ingestion of quercetin-rich onion powder for 12 weeks on visceral Fat: A randomised, double-blind, placebo-controlled, parallel-group study. Nutrients, 2019; 12(1):12010091; doi: 10.3390/nu12010091
26.
PuntelRL, RoosDH, PaixãoMW, et al.Oxalate modulates thiobarbituric acid reactive species (TBARS) production in supernatants of homogenates from rat brain, liver and kidney: Effect of diphenyl diselenide and diphenyl ditelluride. Chem Biol Interact, 2007; 165(2):87–98; doi: 10.1016/j.cbi.2006.11.003
27.
KhanMR, AhmedD. Protective effects of Digera muricata (L.) Mart. on testis against oxidative stress of carbon tetrachloride in rat. Food Chem Toxicol, 2009; 47(6):1393–1399; doi: 10.1016/j.fct.2009.03.020
CaponeV, PersicoN, BerrettiniA, et al.Definition, diagnosis and management of fetal lower urinary tract obstruction: Consensus of the ERKNet CAKUT-obstructive uropathy work group. Nat Rev Urol, 2022; 19(5):295–303; doi: 10.1038/s41585-022-00563-8
30.
ChiangCK, SheuML, LinYW, et al.Honokiol ameliorates renal fibrosis by inhibiting extracellular matrix and pro-inflammatory factors in vivo and in vitro. Br J Pharmacol, 2011; 163(3):586–597; doi: 10.1111/j.1476-5381.2011.01242.x
31.
ElkhadragyMF, Al-OlayanEM, Al-AmieryAA, et al.Protective effects of Fragaria ananassa extract against cadmium chloride-induced acute renal toxicity in rats. Biol Trace Elem Res, 2018; 181(2):378–387; doi: 10.1007/s12011-017-1062-7
32.
IslamMS, GiampieriF, JanjusevicM, et al.An anthocyanin rich strawberry extract induces apoptosis and ROS while decreases glycolysis and fibrosis in human uterine leiomyoma cells. Oncotarget, 2017; 8(14):23575–23587; doi: 10.1863/2/oncotarget.15333
33.
HamedSS, Al-YhyaNA, El-KhadragyMF, et al.The protective properties of the strawberry (Fragaria ananassa) against carbon tetrachloride-induced hepatotoxicity in rats mediated by anti-apoptotic and upregulation of antioxidant genes expression effects. Front Physiol, 2016; 7:325; doi: 10.3389/fphys.2016.00325
34.
GasparriniM, GiampieriF, Forbes-HernandezTY, et al.Strawberry extracts efficiently counteract inflammatory stress induced by the endotoxin lipopolysaccharide in human dermal fibroblast. Food Chem Toxicol, 2018; 114:128–140; doi: 10.1016/j.fct.2018.02.038
35.
WeiX, HouY, LongM, et al.Molecular mechanisms underlying the role of hypoxia-inducible factor-1 α in metabolic reprogramming in renal fibrosis. Front Endocrinol (Lausanne), 2022; 13:927329; doi: 10.3389/fendo.2022.927329
36.
DuanJ, LiY, GaoH, et al.Phenolic compound ellagic acid inhibits mitochondrial respiration and tumor growth in lung cancer. Food Funct, 2020; 11(7):6332–6339; doi: 10.1039/D0FO01177K
37.
WangJ, LiJ, ZhangX, et al.Molecular mechanisms of histone deacetylases and inhibitors in renal fibrosis progression. Front Mol Biosci, 2022; 9:986405; doi: 10.3389/fmolb.2022.986405
38.
WeiJ, XuZ, YanX. The role of the macrophage-to-myofibroblast transition in renal fibrosis. Front Immunol, 2022; 13:934377; doi: 10.3389/fimmu.2022.934377
CaoJX, WangT, LiY, et al.Ellagic acid treatment improves postharvest quality of tomato fruits by enhancing the antioxidant defense system. J Biochem, 2023; 2023:1–10; doi: 10.1155/2023/8375867
41.
JamshidiZ, RoohbakhshA, KarimiG. An overview on the protective effects of ellagic acid against heavy metals, drugs, and chemicals. Food Sci Nutr, 2023; 11(12):7469–7484; doi: 10.1002/fsn3.3704
42.
Iglesias-AguirreCE, García-VillalbaR, BeltránD, et al.Gut bacteria involved in ellagic acid metabolism to yield human urolithin metabotypes revealed. J Agric Food Chem, 2023; 71(9):4029–4035; doi: 10.1021/acs.jafc.2c08889
43.
AndreuxPA, Blanco-BoseW, RyuD, et al.The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nat Metab, 2019; 1(6):595–603; doi: 10.1038/s42255-019-0073-4
44.
GuadaM, GanugulaR, VadhanamM, et al.Urolithin A mitigates cisplatin-induced nephrotoxicity by inhibiting renal inflammation and apoptosis in an experimental rat model. J Pharmacol Exp Ther, 2017; 363(1):58–65; doi: 10.1124/jpet.117.242420
45.
AbdelazeemKNM, KaloMZ, Beer-HammerS, et al.The gut microbiota metabolite urolithin A inhibits NF-κB activation in LPS stimulated BMDMs. Sci Rep, 2021; 11(1):7117; doi: 10.1038/s41598-021-86514-6
46.
Coutinho-WolinoKS, MeloMFS, MotaJC, et al.Blueberry, cranberry, raspberry, and strawberry as modulators of the gut microbiota: Target for treatment of gut dysbiosis in chronic kidney disease? From current evidence to future possibilities. Nutr Rev, 2024; 82(2):248–261; doi: 10.1093/nutrit/nuad048
47.
LinY, FangJ, ZhangZ, et al.Plant flavonoids bioavailability in vivo and mechanisms of benefits on chronic kidney disease: A comprehensive review. Phytochem Rev, 2023; 22(6):1541–1565; doi: 10.1007/s11101-022-09837-w
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
